Next Article in Journal
Structural Characterization of Daunomycin-Peptide Conjugates by Various Tandem Mass Spectrometric Techniques
Next Article in Special Issue
The Multifunctional Sactipeptide Ruminococcin C1 Displays Potent Antibacterial Activity In Vivo as Well as Other Beneficial Properties for Human Health
Previous Article in Journal
A Newly Developed Synbiotic Yogurt Prevents Diabetes by Improving the Microbiome–Intestine–Pancreas Axis
Previous Article in Special Issue
Transgenic Mice Overexpressing PG1 Display Corneal Opacity and Severe Inflammation in the Eye
 
 
Article

Complementary Effects of Carbamylated and Citrullinated LL37 in Autoimmunity and Inflammation in Systemic Lupus Erythematosus

1
Pharmacological Research and Experimental Therapy Unit, National Centre for Pre-Clinical and Clinical Drug Research and Evaluation, Istituto Superiore di Sanità, 00161 Rome, Italy
2
Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy
3
Department of Dermatology, University Hospital CHUV, 1011 Lausanne, Switzerland
4
Department of Clinical and Internistic Sciences, Anesthesiology and Cardiovascular Sciences, University Sapienza, 00161 Rome, Italy
5
Department of Pathology, University Sapienza, 00161 Rome, Italy
6
Confocal Microscopy UNIT, Core Facilities, Istituto Superiore di Sanità, 00161 Rome, Italy
7
National AIDS Center, Istituto Superiore di Sanità, 00161 Rome, Italy
*
Author to whom correspondence should be addressed.
Academic Editor: Gian Marco Ghiggeri
Int. J. Mol. Sci. 2021, 22(4), 1650; https://doi.org/10.3390/ijms22041650
Received: 28 December 2020 / Revised: 27 January 2021 / Accepted: 2 February 2021 / Published: 6 February 2021
(This article belongs to the Special Issue Antimicrobial Peptides and Antimicrobial Chemokines)
LL37 acts as T-cell/B-cell autoantigen in Systemic lupus erythematosus (SLE) and psoriatic disease. Moreover, when bound to “self” nucleic acids, LL37 acts as “danger signal,” leading to type I interferon (IFN-I)/pro-inflammatory factors production. T-cell epitopes derived from citrullinated-LL37 act as better antigens than unmodified LL37 epitopes in SLE, at least in selected HLA-backgrounds, included the SLE-associated HLA-DRB1*1501/HLA-DRB5*0101 backgrounds. Remarkably, while “fully-citrullinated” LL37 acts as better T-cell-stimulator, it loses DNA-binding ability and the associated “adjuvant-like” properties. Since LL37 undergoes a further irreversible post-translational modification, carbamylation and antibodies to carbamylated self-proteins other than LL37 are present in SLE, here we addressed the involvement of carbamylated-LL37 in autoimmunity and inflammation in SLE. We detected carbamylated-LL37 in SLE-affected tissues. Most importantly, carbamylated-LL37-specific antibodies and CD4 T-cells circulate in SLE and both correlate with disease activity. In contrast to “fully citrullinated-LL37,” “fully carbamylated-LL37” maintains both innate and adaptive immune-cells’ stimulatory abilities: in complex with DNA, carbamylated-LL37 stimulates plasmacytoid dendritic cell IFN-α production and B-cell maturation into plasma cells. Thus, we report a further example of how different post-translational modifications of a self-antigen exert complementary effects that sustain autoimmunity and inflammation, respectively. These data also show that T/B-cell responses to carbamylated-LL37 represent novel SLE disease biomarkers. View Full-Text
Keywords: LL37; post-translational modifications (PTM); systemic lupus erythematosus (SLE) LL37; post-translational modifications (PTM); systemic lupus erythematosus (SLE)
Show Figures

Figure 1

MDPI and ACS Style

Lande, R.; Pietraforte, I.; Mennella, A.; Palazzo, R.; Spinelli, F.R.; Giannakakis, K.; Spadaro, F.; Falchi, M.; Riccieri, V.; Stefanantoni, K.; Conrad, C.; Alessandri, C.; Conti, F.; Frasca, L. Complementary Effects of Carbamylated and Citrullinated LL37 in Autoimmunity and Inflammation in Systemic Lupus Erythematosus. Int. J. Mol. Sci. 2021, 22, 1650. https://doi.org/10.3390/ijms22041650

AMA Style

Lande R, Pietraforte I, Mennella A, Palazzo R, Spinelli FR, Giannakakis K, Spadaro F, Falchi M, Riccieri V, Stefanantoni K, Conrad C, Alessandri C, Conti F, Frasca L. Complementary Effects of Carbamylated and Citrullinated LL37 in Autoimmunity and Inflammation in Systemic Lupus Erythematosus. International Journal of Molecular Sciences. 2021; 22(4):1650. https://doi.org/10.3390/ijms22041650

Chicago/Turabian Style

Lande, Roberto, Immacolata Pietraforte, Anna Mennella, Raffaella Palazzo, Francesca Romana Spinelli, Konstantinos Giannakakis, Francesca Spadaro, Mario Falchi, Valeria Riccieri, Katia Stefanantoni, Curdin Conrad, Cristiano Alessandri, Fabrizio Conti, and Loredana Frasca. 2021. "Complementary Effects of Carbamylated and Citrullinated LL37 in Autoimmunity and Inflammation in Systemic Lupus Erythematosus" International Journal of Molecular Sciences 22, no. 4: 1650. https://doi.org/10.3390/ijms22041650

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop